Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs Soligenix Inc. (SNGX)

Kiora Pharmaceuticals, Inc. and Soligenix Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and Soligenix Inc. are of similar size ($7.3M and $6.6M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −50.4%. Across the 15 metrics below, Kiora Pharmaceuticals, Inc. leads on 10 and Soligenix Inc. on 5.

Valuation

Metric KPRX SNGX Biotechnology median
P/E n/m n/m 10.26
P/S 0.49 10.97 9.18
P/B 0.55 0.82 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.59 0.18 0.65
EV/Sales (0.40) (4.05) 8.98
Earnings yield (166.02%) (372.59%) (34.89%)
Free cash flow yield (93.58%) (179.73%) (24.52%)

Profitability

Metric KPRX SNGX Biotechnology median
Gross margin 85.06% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) (241.65%) (50.12%)
Return on assets (39.43%) (125.95%) (45.60%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX SNGX Biotechnology median
Revenue growth (TTM) 983.73% (50.37%) 6.26%
EPS growth (last fiscal year) (403.45%) 57.03% 29.88%
Revenue growth, 5-year CAGR 88.72% (51.88%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX SNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 2.77 4.89
Net debt to EBITDA 1.33 0.67 1.01

Dividend

Metric KPRX SNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KPRX SNGX Biotechnology median
Market cap 6.63m 7.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack